Vol. 7 No. 2 (2025): Ranah Research : Journal Of Multidisciplinary Research and Development

HB E / Thalassemia Beta

##plugins.themes.academic_pro.article.sidebar##

Download
PDF
Statistic

Downloads

Download data is not yet available.

##plugins.themes.academic_pro.article.main##

Hendra Saputra
Program Studi Penyakit Dalam Program Spesialis Fakultas Kedokteran Universitas Andalas, Indonesia
Saptino Miro
Departemen Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Andalas/RSUP Dr. M. Djamil Padang, Indonesia.

Published

Jan 15, 2025

DOI

https://doi.org/10.38035/rrj.v7i2.1349

Abstract

Thalassemia is a blood disorder which characterized with decreased or absence of globin chain in red blood cell thus disrupted hemoglobin synthesis. Hb E/ β-Thalassemia is a thalassemia syndrome of intermedia severity with a very heterogeneous clinical spectrum. The most presented sign and symptoms in Hb E/ β-Thalassemia are pallor and abdominal mass enlargement. One of the most accurate and fast methods to diagnose thalassemia is High Performance Liquid Chromatography. Hb E/ β-Thalassemia based on clinical severity, can start with blood transfusions, and when serum ferritin level increased, it can also begin with iron chelation therapy to prevent complication from iron overload in the body.  We have reported a case of a 28-year-old patient diagnosed with Hb E/ β-Thalassemia, with hemoglobin level is 5,1 g/dL and serum ferritin 1029 ng/mL, started to treat with blood transfusions and iron chelation therapy. Early detection on Hb E/ β-Thalassemia patient will give better outcome to prevent complications caused by the disease it self or treatment given.

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Hak Cipta :

Penulis yang mempublikasikan manuskripnya di jurnal ini menyetujui ketentuan berikut:

  1. Hak cipta pada setiap artikel adalah milik penulis.
  2. Penulis mengakui bahwa Ranah Research : Journal of Multidisciplinary Research and Development berhak menjadi yang pertama menerbitkan dengan lisensi Creative Commons Attribution 4.0 International (Attribution 4.0 International CC BY 4.0) .
  3. Penulis dapat mengirimkan artikel secara terpisah, mengatur distribusi non-eksklusif manuskrip yang telah diterbitkan dalam jurnal ini ke versi lain (misalnya, dikirim ke repositori institusi penulis, publikasi ke dalam buku, dll.), dengan mengakui bahwa manuskrip telah diterbitkan pertama kali di Ranah Research.
How to Cite
Saputra, H. and Saptino Miro (2025) “HB E / Thalassemia Beta”, Ranah Research : Journal of Multidisciplinary Research and Development, 7(2), pp. 1242-1249. doi: 10.38035/rrj.v7i2.1349.

References

1. Shafique F, Ali S, Almansouri T, Eeden FV, Shafi N, Khalid M, et al. Thalassemia, a human blood disorder. Brazilian Journal of Biology. 2021: 1-8.
2. Lee JS, Rhee TM, Jeon K, Cho Y, Lee SW, Han KD, et al. Epidemiologic Trends of Thalassemia, 2006-2018 : A Nationwide Population-Based Study. J. Clin. Med. 2022: 11; 1-9.
3. Rujito L. Thalassemia : Genetik Dasar dan Pengelolaan Terkini. Unsoed Press. Jawa Tengah. 2019;(1): 1-90.
4. Silberstein PT, Do V, Tran H. The Thalassemias. Elsevier. 2014:1-5.
5. Kemenkes. Pedoman Nasional Pelayanan Kedokteran Tatalaksana Thalasemia. Keputusan Menteri Kesehatan. Jakarta. 2018: 17-18.
6. Setiati S, Alwi I, Sudoyo AW, Stiyohadi B, Syam AF. Buku Ajar Ilmi Penyakit Dalam Jilid I. Edisi VI. Internal Publishing. Jakarta. 2014: 2635-2636.
7. Brancaleoni V, Pierro ED, Motta I, Cappellini MD. Laboratory diagnosis of thalassemia. Int. Jnl. Lab. Hem. 2016:38;32-40.
8. Turner J, Parsi M, Badireddy M. Anemia. StatPearls Publishing. 2022:1-7.
9. Kim YJ, Han KD, Cho KH, Kim YH, Park YG. Anemia and health-related quality of life in South Korea: data from the Korean national health and nutrition examination survey 2008-2016. BMC Public Health. 2019:19;735.
10. Bakta IM. Hematologi Klinik Ringkas. Jakarta : ECG. 2012 : 9-39.
11. Baldwin C, Pandey J, Olarewaju O. Hemolytic Anemia. Treasure Island. StatPearls Publishing. 2022:1-7.
12. Khera R, Singh T, Khuana N, Gupta N, Dubey AP. HPLC in Characterization of Hemoglobin Profile in Thalassemia Syndromes and Hemoglobinopathies: A Clinicohematological Correlation. Indian J Hematol Blood Transfus. 2015:31(1)110-115.
13. Rujito L. Talasemia : Genetik Dasar dan Pengelolaan Terkini. Unsoed Press. Jawa Tengah. 2019: (1)1-90.
14. Fucharoen S, Weatherall DJ. The Hemoglobin E Thalassemias. Cold Spring Harbor Laboratory Press. 2012:1-15.
15. 15. Klutstein MW, Tzivoni. Anaemia and heart failure : aetiology and treatment. Nephrol Dial Transplant.2005: (20)vii7-vii10.
16. Park SK, Jung JY, Kang JG, Hong HP, Oh CM. Association of Left Ventricular Hypertrophy with Hemoglobin Levels in Nonanemic and Anemic Populations. Cardiology.2020;145:485-491.
17. Musallam KM. Iron overload in non-transfusion-dependent thalassemia. Thalassemia Reports. 2013;3(s1):e11.
18. Udin MM, Haq FU, Sarfaraz A, Khan MMA, Nazim A, Maqsood B (et al). Frequency and awareness of thalassemia families with cousin Marriages : A study from Karachi, Pakistan. British Journal of Medicine & Medical Research. 2017 : 21 (3) : 1 – 11 ISSN : 2231-0614.